Especialidad en implantes de celulas madres desde tejido graso y medula osea de origen autologo
The Global Stem Cells Group owns a proprietary protocol to harvest adult stem cells from adipose tissue as well as bone marrow. This proprietary, research-backed technique, coupled with the company’s synergistic strategy that includes platforms for research, education, and treatment, provides a measura
ble market advantage as well as assurance that our patients and physicians will enjoy the most favorable possible outcomes from stem cell treatments. No other company offers the breadth of education, research and treatment options that The Global Stem Cells Group can offer. The Global Stem Cells Group’s companies offer everything necessary for physicians to begin utilizing stem cell therapy treatments with their patients. In addition, the company offers consumer and patient education that will continue to fuel demand for the treatments. Research indicates that stem cell therapies are poised for explosive growth worldwide, and new products for treatments of diabetes, cardiovascular disease and nerve repair are on the horizon. Our unique approach incorporating research, education and treatment positions us to become the recognized leader in autologous stem cell treatments.
